報價延遲最少15分鐘:2025/01/21 08:44 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.12/-1.21
|
|
企業價值
59.15M
|
| 資產負債 |
|
每股賬面淨值
1.96
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
22.52M
|
|
每股收益
0.48
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:44 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell andgene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services. |